$352 Million is the total value of Parkman Healthcare Partners LLC's 89 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 46.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $17,226,000 | -20.4% | 82,270 | -10.4% | 4.90% | -38.5% |
UNH | Sell | UNITEDHEALTH GROUP INC | $13,960,000 | -5.7% | 27,641 | -4.1% | 3.97% | -27.2% |
DHR | Buy | DANAHER CORPORATION | $13,691,000 | +40.4% | 53,006 | +37.8% | 3.89% | +8.4% |
BSX | New | BOSTON SCIENTIFIC CORP | $13,470,000 | – | 347,787 | +100.0% | 3.83% | – |
NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $12,469,000 | +49.5% | 117,400 | +37.2% | 3.54% | +15.4% |
LLY | New | LILLY ELI & CO | $11,409,000 | – | 35,285 | +100.0% | 3.24% | – |
CVS | Buy | CVS HEALTH CORP | $11,219,000 | +126.1% | 117,634 | +119.7% | 3.19% | +74.6% |
IONS | Buy | IONIS PHARMACEUTICALS INC | $10,701,000 | +65.8% | 241,945 | +38.8% | 3.04% | +28.0% |
SGEN | Sell | SEAGEN INC | $9,906,000 | -26.9% | 72,397 | -5.5% | 2.82% | -43.6% |
HAE | Buy | HAEMONETICS CORP MASS | $8,572,000 | +425.9% | 115,797 | +363.2% | 2.44% | +306.2% |
THC | Buy | TENET HEALTHCARE CORP | $8,202,000 | +69.3% | 159,024 | +72.5% | 2.33% | +30.6% |
XENE | Sell | XENON PHARMACEUTICALS INC | $8,036,000 | -10.3% | 222,597 | -24.4% | 2.28% | -30.8% |
ANTM | Sell | ELEVANCE HEALTH INC | $7,811,000 | -8.8% | 17,196 | -3.1% | 2.22% | -29.6% |
CDMO | Sell | AVID BIOSERVICES INC | $7,740,000 | +10.0% | 404,818 | -12.2% | 2.20% | -15.1% |
CNCE | Buy | CONCERT PHARMACEUTICALS INC | $7,622,000 | +61.1% | 1,137,587 | +1.2% | 2.17% | +24.3% |
WAT | Buy | WATERS CORP | $7,447,000 | -14.3% | 27,630 | +5.3% | 2.12% | -33.8% |
CTIC | Buy | CTI BIOPHARMA CORP | $7,043,000 | +12.2% | 1,210,145 | +15.1% | 2.00% | -13.4% |
EW | New | EDWARDS LIFESCIENCES CORP | $6,768,000 | – | 81,906 | +100.0% | 1.92% | – |
IQV | Sell | IQVIA HLDGS INC | $6,371,000 | -26.0% | 35,171 | -11.4% | 1.81% | -42.9% |
DCPH | New | DECIPHERA PHARMACEUTICALS IN | $5,585,000 | – | 301,892 | +100.0% | 1.59% | – |
Buy | R1 RCM INC | $5,160,000 | +6.9% | 278,486 | +20.9% | 1.47% | -17.5% | |
LEGN | Buy | LEGEND BIOTECH CORPsponsored ads | $4,946,000 | -23.7% | 121,227 | +2.9% | 1.41% | -41.1% |
ATEC | Buy | ALPHATEC HLDGS INC | $4,764,000 | +39.1% | 545,133 | +4.1% | 1.35% | +7.4% |
NTRA | Buy | NATERA INC | $4,610,000 | +75.7% | 105,201 | +42.1% | 1.31% | +35.7% |
RYTM | New | RHYTHM PHARMACEUTICALS INC | $4,606,000 | – | 187,989 | +100.0% | 1.31% | – |
DAWN | Buy | DAY ONE BIOPHARMACEUTICALS I | $4,250,000 | +106.9% | 212,191 | +84.9% | 1.21% | +59.8% |
Buy | PROCEPT BIOROBOTICS CORP | $4,196,000 | +35.8% | 101,201 | +7.1% | 1.19% | +4.8% | |
PODD | Buy | INSULET CORP | $3,912,000 | +29.2% | 17,054 | +22.8% | 1.11% | -0.3% |
STRO | Buy | SUTRO BIOPHARMA INC | $3,815,000 | +297.0% | 687,335 | +272.5% | 1.08% | +206.5% |
TMO | New | THERMO FISHER SCIENTIFIC INC | $3,804,000 | – | 7,500 | +100.0% | 1.08% | – |
ANIP | Buy | ANI PHARMACEUTICALS INC | $3,791,000 | +17.7% | 117,941 | +8.6% | 1.08% | -9.1% |
KROS | Buy | KEROS THERAPEUTICS INC | $3,759,000 | +184.8% | 99,927 | +109.1% | 1.07% | +120.0% |
ACRS | Sell | ACLARIS THERAPEUTICS INC | $3,677,000 | -13.6% | 233,626 | -23.4% | 1.04% | -33.3% |
BMRN | New | BIOMARIN PHARMACEUTICAL INC | $3,642,000 | – | 42,961 | +100.0% | 1.04% | – |
APEN | Buy | APOLLO ENDOSURGERY INC | $3,624,000 | +52.7% | 657,690 | +1.2% | 1.03% | +17.8% |
RCUS | Sell | ARCUS BIOSCIENCES INC | $3,607,000 | -16.9% | 137,894 | -19.5% | 1.02% | -35.9% |
COGT | Sell | COGENT BIOSCIENCES INC | $3,532,000 | +35.6% | 236,697 | -18.0% | 1.00% | +4.7% |
VRNA | New | VERONA PHARMA PLCsponsored ads | $3,304,000 | – | 323,273 | +100.0% | 0.94% | – |
CTLT | Sell | CATALENT INC | $3,278,000 | -54.8% | 45,304 | -33.0% | 0.93% | -65.1% |
DXCM | Buy | DEXCOM INC | $3,250,000 | +25.2% | 40,358 | +15.9% | 0.92% | -3.3% |
IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $3,189,000 | -60.1% | 25,458 | -65.6% | 0.91% | -69.2% |
NSTG | New | NANOSTRING TECHNOLOGIES INC | $3,098,000 | – | 242,600 | +100.0% | 0.88% | – |
SDGR | Buy | SCHRODINGER INC | $3,090,000 | -4.3% | 123,679 | +1.2% | 0.88% | -26.2% |
SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $3,037,000 | +18.4% | 89,709 | +1.2% | 0.86% | -8.6% |
MNKD | Buy | MANNKIND CORP | $2,858,000 | -1.9% | 924,979 | +20.9% | 0.81% | -24.2% |
Buy | IMAGO BIOSCIENCES INC | $2,847,000 | +44.2% | 189,193 | +28.4% | 0.81% | +11.3% | |
ISRG | New | INTUITIVE SURGICAL INC | $2,812,000 | – | 15,000 | +100.0% | 0.80% | – |
COO | Buy | COOPER COS INC | $2,803,000 | -14.8% | 10,622 | +1.2% | 0.80% | -34.2% |
LNTH | Buy | LANTHEUS HLDGS INC | $2,791,000 | +97.2% | 39,682 | +85.2% | 0.79% | +52.2% |
KRTX | New | KARUNA THERAPEUTICS INC | $2,699,000 | – | 12,000 | +100.0% | 0.77% | – |
Sell | ARCELLX INC | $2,625,000 | -18.4% | 139,875 | -21.4% | 0.75% | -37.0% | |
AXGN | Buy | AXOGEN INC | $2,384,000 | +54.4% | 200,000 | +6.1% | 0.68% | +19.2% |
ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $2,176,000 | -28.0% | 10,873 | -47.6% | 0.62% | -44.4% |
IMUX | Buy | IMMUNIC INC | $2,078,000 | -7.9% | 657,643 | +1.2% | 0.59% | -28.9% |
Buy | RXSIGHT INC | $2,001,000 | +23.6% | 166,761 | +45.0% | 0.57% | -4.5% | |
ESPR | New | ESPERION THERAPEUTICS INC NE | $1,986,000 | – | 296,381 | +100.0% | 0.56% | – |
FULC | Sell | FULCRUM THERAPEUTICS INC | $1,904,000 | +47.9% | 235,385 | -10.4% | 0.54% | +14.1% |
AKYA | Sell | AKOYA BIOSCIENCES INC | $1,900,000 | -20.0% | 161,701 | -12.5% | 0.54% | -38.2% |
BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $1,893,000 | +86.7% | 81,364 | +34.7% | 0.54% | +44.2% |
PFMT | Buy | PERFORMANT FINL CORP | $1,893,000 | -28.8% | 1,023,350 | +1.2% | 0.54% | -45.1% |
LNDC | Buy | LANDEC CORP | $1,798,000 | +48.2% | 202,248 | +66.3% | 0.51% | +14.3% |
TMDX | New | TRANSMEDICS GROUP INC | $1,768,000 | – | 42,358 | +100.0% | 0.50% | – |
XFOR | New | X4 PHARMACEUTICALS INC | $1,625,000 | – | 950,000 | +100.0% | 0.46% | – |
KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $1,620,000 | +34.1% | 126,192 | +1.2% | 0.46% | +3.6% |
KRMD | Buy | KORU MEDICAL SYSTEMS INC | $1,524,000 | -10.8% | 683,466 | +1.2% | 0.43% | -31.2% |
MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $1,403,000 | -8.1% | 21,590 | +1.2% | 0.40% | -29.0% |
LQDA | New | LIQUIDIA CORPORATION | $1,384,000 | – | 254,452 | +100.0% | 0.39% | – |
ETNB | New | 89BIO INC | $1,303,000 | – | 225,000 | +100.0% | 0.37% | – |
SLN | Buy | SILENCE THERAPEUTICS PLCads | $1,279,000 | +311.3% | 127,458 | +385.6% | 0.36% | +216.5% |
VCYT | Sell | VERACYTE INC | $1,011,000 | -31.3% | 60,883 | -17.7% | 0.29% | -47.0% |
XAIR | New | BEYOND AIR INC | $941,000 | – | 126,442 | +100.0% | 0.27% | – |
TELA | Buy | TELA BIO INC | $940,000 | +23.0% | 110,280 | +1.2% | 0.27% | -5.0% |
New | PEPGEN INC | $908,000 | – | 100,000 | +100.0% | 0.26% | – | |
ISEE | New | IVERIC BIO INC | $897,000 | – | 50,000 | +100.0% | 0.26% | – |
MIRM | Buy | MIRUM PHARMACEUTICALS INC | $891,000 | +43.0% | 42,395 | +32.4% | 0.25% | +10.5% |
ESTA | New | ESTABLISHMENT LABS HLDGS INC | $829,000 | – | 15,173 | +100.0% | 0.24% | – |
OPNT | Buy | OPIANT PHARMACEUTICALS INC | $823,000 | -9.3% | 76,530 | +1.2% | 0.23% | -29.9% |
HBIO | Sell | HARVARD BIOSCIENCE INC | $782,000 | -38.2% | 305,353 | -13.2% | 0.22% | -52.4% |
LXRX | Buy | LEXICON PHARMACEUTICALS INC | $729,000 | +56.8% | 303,614 | +21.4% | 0.21% | +21.1% |
VRDN | New | VIRIDIAN THERAPEUTICS INC | $725,000 | – | 35,358 | +100.0% | 0.21% | – |
TVTX | Buy | TRAVERE THERAPEUTICS INC | $655,000 | +3.0% | 26,565 | +1.2% | 0.19% | -20.5% |
CDXS | Sell | CODEXIS INC | $638,000 | -70.1% | 105,319 | -48.4% | 0.18% | -77.0% |
PSTV | Sell | PLUS THERAPEUTICS INC | $590,000 | -28.7% | 1,325,025 | -13.6% | 0.17% | -44.9% |
EWTX | New | EDGEWISE THERAPEUTICS INC | $492,000 | – | 50,000 | +100.0% | 0.14% | – |
TKNO | Buy | ALPHA TEKNOVA INC | $406,000 | -59.7% | 121,424 | +1.2% | 0.12% | -69.0% |
STIM | New | NEURONETICS INC | $273,000 | – | 85,866 | +100.0% | 0.08% | – |
BLRX | Buy | BIOLINERX LTDsponsored ads | $267,000 | -26.8% | 288,852 | +1.2% | 0.08% | -43.3% |
SIEN | Sell | SIENTRA INC | $239,000 | -31.9% | 373,586 | -10.9% | 0.07% | -47.3% |
UBX | New | UNITY BIOTECHNOLOGY INC | $160,000 | – | 404,092 | +100.0% | 0.04% | – |
SURF | Exit | SURFACE ONCOLOGY INC | $0 | – | -115,577 | -100.0% | -0.07% | – |
EIGR | Exit | EIGER BIOPHARMACEUTICALS INC | $0 | – | -52,733 | -100.0% | -0.12% | – |
RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -26,677 | -100.0% | -0.14% | – |
ALLK | Exit | ALLAKOS INC | $0 | – | -160,376 | -100.0% | -0.18% | – |
FMTX | Exit | FORMA THERAPEUTICS HLDGS INC | $0 | – | -78,603 | -100.0% | -0.20% | – |
PHAT | Exit | PHATHOM PHARMACEUTICALS INC | $0 | – | -69,135 | -100.0% | -0.22% | – |
ZYME | Exit | ZYMEWORKS INC | $0 | – | -125,806 | -100.0% | -0.25% | – |
HCAT | Exit | HEALTH CATALYST INC | $0 | – | -63,104 | -100.0% | -0.34% | – |
MASS | Exit | 908 DEVICES INC | $0 | – | -149,315 | -100.0% | -1.13% | – |
AVTR | Exit | AVANTOR INC | $0 | – | -172,269 | -100.0% | -1.97% | – |
ALT | Exit | ALTIMMUNE INC | $0 | – | -559,755 | -100.0% | -2.41% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
DEXCOM INC | 16 | Q3 2023 | 6.3% |
ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
XENON PHARMACEUTICALS INC | 16 | Q3 2023 | 3.3% |
NATERA INC | 16 | Q3 2023 | 3.4% |
AVID BIOSERVICES INC | 15 | Q3 2023 | 2.9% |
SCHRODINGER INC | 15 | Q3 2023 | 4.2% |
REPRO MED SYS INC | 15 | Q2 2023 | 2.0% |
MANNKIND CORP | 15 | Q3 2023 | 1.6% |
IQVIA HLDGS INC | 14 | Q1 2023 | 4.6% |
INSULET CORP | 14 | Q3 2023 | 2.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
SC 13G/A | 2023-02-13 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-11 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.